Reminder: GLP-1 receptor agonists interactions with oral contraception – safety guidance
Pharmacy owners providing the Pharmacy Contraception Service are reminded that the Faculty of Sexual & Reproductive Healthcare (FSRH) advises that individuals use contraception whilst using Glucagon-like peptide-1 (GLP-1) agonists, with additional advice for those using tirzepatide. The statement from the FSRH can be found at: FSRH statement: Glucagon-like peptide-1 (GLP-1) agonists and oral contraception (Feb [...]
The post Reminder: GLP-1 receptor agonists interactions with oral contraception – safety guidance appeared first on Community Pharmacy England.
Recent Comments